[시장보고서]세계의 원발성 면역결핍증 치료 시장(2024-2028년)

세계의 원발성 면역결핍증 치료 시장(2024-2028년)

Global Primary Immunodeficiency Therapeutics Market 2024-2028

상품코드 : 1544450 해당 상품은 즉시 배송 가능합니다

리서치사 : TechNavio

발행일 : 2024년 07월

페이지 정보 : 영문 136 Pages

라이선스 & 가격 (부가세 별도)

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

원발성 면역결핍증 치료 시장은 2023-2028년 16억 9,950만 달러 규모로 예측기간 동안 4.5%의 CAGR로 성장할 것으로 예상됩니다. 본 보고서는 원발성 면역결핍증 치료 시장에 대한 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 전해드립니다.

현재 시장 시나리오, 최신 동향 및 촉진요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 면역결핍 질환의 유병률 증가, 소아의 면역 질환 발병률 증가, 유전자 치료의 기술적 진보에 의해 주도되고 있습니다.

시장 범위
기준 연도	2024년
종료 연도	2028년
예측 기간	2024-2028년
성장 모멘텀	가속
전년 대비[2024년]	4.23%
CAGR	4.5%
증분 금액	16억 9,950만 달러

이 보고서는 향후 몇 년 동안 원발성 면역결핍증 치료 시장의 성장을 촉진하는 주요 이유 중 하나로 연구개발 활동의 증가를 꼽았습니다. 또한, 유전자 기술의 발전과 면역결핍증에 대한 정부의 인식 제고 프로그램 증가도 시장의 큰 수요로 이어질 것입니다.

지역별 세분화
비교 : 지역별
북미 : 시장 규모와 예측 2023-2028년
유럽 : 시장 규모와 예측 2023-2028년
아시아 : 시장 규모와 예측 2023-2028년
기타 : 시장 규모와 예측 2023-2028년
미국 : 시장 규모와 예측 2023-2028년
독일 : 시장 규모와 예측 2023-2028년
중국 : 시장 규모와 예측 2023-2028년
영국 : 시장 규모와 예측 2023-2028년
캐나다 : 시장 규모와 예측 2023-2028년
시장 기회 : 지역 상황별

제9장 촉진요인, 과제, 기회, 억제요인

시장 성장 촉진요인
시장 과제
성장 촉진요인과 과제의 영향
시장 기회·억제요인

제10장 경쟁 상황

개요
경쟁 상황
혼란 상황
업계 리스크

제11장 경쟁 분석

기업 개요
기업의 시장 포지셔닝
Bayer AG
Bio Products Laboratory Ltd.
Biocon Ltd.
Biotest AG
CSL Ltd.
Grifols SA
Kedrion Spa
Octapharma AG
Pfizer Inc.
Takeda Pharmaceutical Co. Ltd.

제12장 부록

ksm

영문 목차

영문목차

The primary immunodeficiency therapeutics market is forecasted to grow by USD 1699.5 mn during 2023-2028, accelerating at a CAGR of 4.5% during the forecast period. The report on the primary immunodeficiency therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of immunodeficiency diseases, rising incidences of immune diseases in children, and technological advancements in gene therapy.

Technavio's primary immunodeficiency therapeutics market is segmented as below:

Market Scope
Base Year	2024
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	4.23%
CAGR	4.5%
Incremental Value	$1699.5 mn

By Disease Type

Antibody deficiency
Cellular immunodeficiency
Innate immune disorders

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing r and d activities as one of the prime reasons driving the primary immunodeficiency therapeutics market growth during the next few years. Also, advancements in genetic technology and rise in government awareness programs about immunodeficiency diseases will lead to sizable demand in the market.

The report on the primary immunodeficiency therapeutics market covers the following areas:

Primary immunodeficiency therapeutics market sizing
Primary immunodeficiency therapeutics market forecast
Primary immunodeficiency therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading primary immunodeficiency therapeutics market vendors that include ADMA Biologics Inc., Astellas Pharma Inc., Baxter International Inc., Bayer AG, Bio Products Laboratory Ltd., Biocon Ltd., Biotest AG, CSL Ltd., Grifols SA, Kedrion Spa, LFB SA, Lupin Ltd., Octapharma AG, Pfizer Inc., Sanquin, and Takeda Pharmaceutical Co. Ltd.. Also, the primary immunodeficiency therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary

1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Disease Type
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
2.2 Market characteristics
- Market characteristics analysis
2.3 Value chain analysis
- Value Chain Analysis

3 Market Sizing

3.1 Market definition
- Offerings of companies included in the market definition
3.2 Market segment analysis
- Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
- Chart on Global - Market size and forecast 2023-2028 ($ million)
- Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global Primary Immunodeficiency Therapeutics Market 2018 - 2022
- Historic Market Size - Data Table on Global Primary Immunodeficiency Therapeutics Market 2018 - 2022 ($ million)
4.2 Disease Type segment analysis 2018 - 2022
- Historic Market Size - Disease Type Segment 2018 - 2022 ($ million)
4.3 Geography segment analysis 2018 - 2022
- Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.4 Country segment analysis 2018 - 2022
- Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
- Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Disease Type

6.1 Market segments
- Chart on Disease Type - Market share 2023-2028 (%)
- Data Table on Disease Type - Market share 2023-2028 (%)
6.2 Comparison by Disease Type
- Chart on Comparison by Disease Type
- Data Table on Comparison by Disease Type
6.3 Antibody deficiency - Market size and forecast 2023-2028
- Chart on Antibody deficiency - Market size and forecast 2023-2028 ($ million)
- Data Table on Antibody deficiency - Market size and forecast 2023-2028 ($ million)
- Chart on Antibody deficiency - Year-over-year growth 2023-2028 (%)
- Data Table on Antibody deficiency - Year-over-year growth 2023-2028 (%)
6.4 Cellular immunodeficiency - Market size and forecast 2023-2028
- Chart on Cellular immunodeficiency - Market size and forecast 2023-2028 ($ million)
- Data Table on Cellular immunodeficiency - Market size and forecast 2023-2028 ($ million)
- Chart on Cellular immunodeficiency - Year-over-year growth 2023-2028 (%)
- Data Table on Cellular immunodeficiency - Year-over-year growth 2023-2028 (%)
6.5 Innate immune disorders - Market size and forecast 2023-2028
- Chart on Innate immune disorders - Market size and forecast 2023-2028 ($ million)
- Data Table on Innate immune disorders - Market size and forecast 2023-2028 ($ million)
- Chart on Innate immune disorders - Year-over-year growth 2023-2028 (%)
- Data Table on Innate immune disorders - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by Disease Type
- Market opportunity by Disease Type ($ million)
- Data Table on Market opportunity by Disease Type ($ million)

7 Customer Landscape

7.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

8.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2023-2028 (%)
- Data Table on Market share By Geographical Landscape 2023-2028 (%)
8.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
- Chart on North America - Market size and forecast 2023-2028 ($ million)
- Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Chart on North America - Year-over-year growth 2023-2028 (%)
- Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
- Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Chart on Europe - Year-over-year growth 2023-2028 (%)
- Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 Asia - Market size and forecast 2023-2028
- Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Chart on Asia - Year-over-year growth 2023-2028 (%)
- Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 US - Market size and forecast 2023-2028
- Chart on US - Market size and forecast 2023-2028 ($ million)
- Data Table on US - Market size and forecast 2023-2028 ($ million)
- Chart on US - Year-over-year growth 2023-2028 (%)
- Data Table on US - Year-over-year growth 2023-2028 (%)
8.8 Germany - Market size and forecast 2023-2028
- Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Chart on Germany - Year-over-year growth 2023-2028 (%)
- Data Table on Germany - Year-over-year growth 2023-2028 (%)
8.9 China - Market size and forecast 2023-2028
- Chart on China - Market size and forecast 2023-2028 ($ million)
- Data Table on China - Market size and forecast 2023-2028 ($ million)
- Chart on China - Year-over-year growth 2023-2028 (%)
- Data Table on China - Year-over-year growth 2023-2028 (%)
8.10 UK - Market size and forecast 2023-2028
- Chart on UK - Market size and forecast 2023-2028 ($ million)
- Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Chart on UK - Year-over-year growth 2023-2028 (%)
- Data Table on UK - Year-over-year growth 2023-2028 (%)
8.11 Canada - Market size and forecast 2023-2028
- Chart on Canada - Market size and forecast 2023-2028 ($ million)
- Data Table on Canada - Market size and forecast 2023-2028 ($ million)
- Chart on Canada - Year-over-year growth 2023-2028 (%)
- Data Table on Canada - Year-over-year growth 2023-2028 (%)
8.12 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)

9 Drivers, Challenges, and Opportunity/Restraints

9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints

10 Competitive Landscape

10.1 Overview
10.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
- Overview on factors of disruption
10.4 Industry risks
- Impact of key risks on business

11 Competitive Analysis

11.1 Companies profiled
- Companies covered
11.2 Market positioning of companies
- Matrix on companies position and classification
11.3 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
11.4 Bio Products Laboratory Ltd.
- Bio Products Laboratory Ltd. - Overview
- Bio Products Laboratory Ltd. - Product / Service
- Bio Products Laboratory Ltd. - Key offerings
11.5 Biocon Ltd.
- Biocon Ltd. - Overview
- Biocon Ltd. - Business segments
- Biocon Ltd. - Key offerings
- Biocon Ltd. - Segment focus
11.6 Biotest AG
- Biotest AG - Overview
- Biotest AG - Business segments
- Biotest AG - Key offerings
- Biotest AG - Segment focus
11.7 CSL Ltd.
- CSL Ltd. - Overview
- CSL Ltd. - Business segments
- CSL Ltd. - Key news
- CSL Ltd. - Key offerings
- CSL Ltd. - Segment focus
11.8 Grifols SA
- Grifols SA - Overview
- Grifols SA - Business segments
- Grifols SA - Key news
- Grifols SA - Key offerings
- Grifols SA - Segment focus
11.9 Kedrion Spa
- Kedrion Spa - Overview
- Kedrion Spa - Product / Service
- Kedrion Spa - Key offerings
11.10 Octapharma AG
- Octapharma AG - Overview
- Octapharma AG - Product / Service
- Octapharma AG - Key offerings
11.11 Pfizer Inc.
- Pfizer Inc. - Overview
- Pfizer Inc. - Product / Service
- Pfizer Inc. - Key news
- Pfizer Inc. - Key offerings
11.12 Takeda Pharmaceutical Co. Ltd.
- Takeda Pharmaceutical Co. Ltd. - Overview
- Takeda Pharmaceutical Co. Ltd. - Product / Service
- Takeda Pharmaceutical Co. Ltd. - Key news
- Takeda Pharmaceutical Co. Ltd. - Key offerings

12 Appendix

12.1 Scope of the report
12.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
12.3 Currency conversion rates for US$
- Currency conversion rates for US$
12.4 Research methodology
- Research methodology
12.5 Data procurement
- Information sources
12.6 Data validation
- Data validation
12.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
12.8 Data synthesis
- Data synthesis
12.9 360 degree market analysis
- 360 degree market analysis
12.10 List of abbreviations
- List of abbreviations

한글목차

목차

제1장 주요 요약

제2장 시장 상황

제3장 시장 규모 평가

제4장 시장 규모 실적

제5장 Five Forces 분석

제6장 시장 세분화 : 질환 유형별

제7장 고객 상황

제8장 지역별 상황